Akeso’s Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA by Investing.com
Hong Kong, January 26, 2025 /prnewswire/- Akeso, Inc. (9926.hk)("AkesoThe Company (or the…
Mumbai lake water level to cross 38 per cent on July 18; city expected to receive moderate to heavy rainfall today
The lake that supplies Mumbai with drinking water is at 38.47 per…
